Enovix/$ENVX

ENVX falls as Q3 earnings issued Q4 revenue guidance of $9.5m–$10.5m below $12.05m consensus and adjusted loss guidance of $0.16–$0.20 above $0.14 est.
19 hours agoLightyear AI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Enovix

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

Ticker

$ENVX
Sector
Industrials
Primary listing
NASDAQ

Employees

570
Headquarters
Fremont, United States
Website
www.enovix.com

Enovix Metrics

BasicAdvanced
$1.8B
-
-$0.82
-
-

What the Analysts think about Enovix

Analyst ratings (Buy, Hold, Sell) for Enovix stock.

Bulls say / Bears say

Enovix’s Q2 2025 GAAP revenue grew 98% year-over-year to $7.5 million, exceeding both its guidance range of $4.5 million to $6.5 million and analyst expectations, thanks to strong demand in defense and consumer electronics. (Nasdaq)
Enovix posted its third consecutive quarter of positive gross profit in Q2 2025, with GAAP gross profit of $0.8 million and non-GAAP gross profit of $1.2 million. Higher yields at its South Korea plant improved margins into the low 30% range. (Investing.com)
After a $232 million warrant dividend payout and a $360 million convertible note issue, Enovix reported a pro forma cash balance of $674 million at the end of Q2 2025, providing significant liquidity for Fab2 expansion and R&D investment. (Investing.com)
Despite strong top-line growth, Enovix’s Q2 2025 GAAP net loss remained substantial at $43.3 million, pointing to ongoing unprofitability as production volumes increase. (Nasdaq)
The company’s non-GAAP operating loss narrowed only slightly to $27.8 million in Q2 2025, highlighting continued high cash burn and limited operating leverage. (Investing.com)
Enovix’s announcement of a planned $300 million convertible senior notes offering in September 2025 signals its continued dependence on potentially dilutive financing to sustain operations and manufacturing scale-up. (GlobeNewswire)
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.

Enovix Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Enovix Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

Enovix News

AllArticlesVideos
Halper Sadeh LLC Encourages Enovix Corp. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages Enovix Corp. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire2 weeks ago
Best Stocks Under $15? 3 Low-Priced Picks With Upside

Best Stocks Under $15? 3 Low-Priced Picks With Upside

MarketBeat1 month ago
Enovix Stock Tumbles After Hours: What To Know

Enovix Stock Tumbles After Hours: What To Know

Benzinga2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ENVX

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs